EBV can establish a prolonged latent and intermittent reactivation within B cells (150), potentially resulting in a series of CD8+ T cells immune responses, suggesting that B cells may represent essential players in promoting chronic CD8+ T lymphocyte activity in MS (151). Here, CD8A is linked to myeloid sarcoma.